$6.87
+0.28 (+4.25%)
Open$6.68
Previous Close$6.59
Day High$6.94
Day Low$6.48
52W High$12.23
52W Low$2.59
Volume—
Avg Volume627.3K
Market Cap159.21M
P/E Ratio—
EPS$-0.81
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+641.2% upside
Current
$6.87
$6.87
Target
$50.92
$50.92
$37.48
$50.92 avg
$70.07
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 71.57M | 63.07M | 17.09M |
| Net Income | -21,446,299 | -17,008,873 | -4,142,594 |
| Profit Margin | -30.0% | -28.5% | -24.3% |
| EBITDA | -13,165,812 | -11,021,784 | -7,262,848 |
| Free Cash Flow | — | — | -5,494,601 |
| Rev Growth | +13.5% | +13.5% | +9.1% |
| Debt/Equity | 1.49 | 1.49 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $249.46 | -0.54% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $415.21 | -0.63% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $138.36 | +0.16% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $505.75 | -2.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $803.48 | -0.31% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $228.65 | +0.67% | 37.6 | 30.39B |